Serum cystatin C as a potential biomarker for the evaluation COPD
Yonghong Zhang1, Yanting Zhu1, Yuanyuan Wu1
1Department of Respiratory Medicine, Second Affiliated Hospital of Medical College, Xi'an Jiaotong University Xi'an 710004, Shanxi, People's Republic of China.
International Journal of Clinical and Experimental Medicine
|February 10, 2015
Summary
Serum cystatin C levels are higher in patients with chronic obstructive pulmonary disease (COPD). This protein may serve as a biomarker for lung tissue destruction and disease severity.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Biomarker Discovery
Background:
- Protease-antiprotease imbalance is key in chronic obstructive pulmonary disease (COPD) pathogenesis.
- Cystatin C, a cysteine protease inhibitor in blood, contributes to lung tissue destruction.
Purpose of the Study:
- To evaluate serum cystatin C as a potential biomarker for COPD evaluation and monitoring.
- To investigate the relationship between cystatin C levels and COPD severity.
Main Methods:
- Serum cystatin C levels were measured in patients with acute exacerbation of COPD (AECOPD), stable COPD (SCOPD), and healthy controls.
- The study analyzed the impact of smoking on serum cystatin C and its correlation with lung function parameters.
Main Results:
- COPD patients exhibited significantly higher serum cystatin C levels compared to controls.
- Serum cystatin C levels correlated negatively with FEV1% predicted, indicating a link to reduced lung function.
- Smoking elevated cystatin C in stable COPD but not in AECOPD or controls.
Conclusions:
- Elevated serum cystatin C is characteristic of COPD.
- Cystatin C shows potential as a biomarker for assessing lung tissue damage and COPD severity.
- FEV1% predicted is an independent predictor of serum cystatin C levels in COPD.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.4K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
783
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
783
01:24Serum Studies: Renal Function Tests
658
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
658
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
01:23Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
943
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
943